Lease Agreements in the Biotechnology Industry

2,455 Contracts & Agreements

Browse by Company

89bio, Inc. (3 contracts)
ACADIA PHARMACEUTICALS INC (10)
ACCELERON PHARMA INC (2)
Achaogen, Inc. (7)
ACHIEVE LIFE SCIENCES, INC. (9)
Acorda Therapeutics (4)
Actinium Pharmaceuticals, Inc. (2)
Acumen Pharmaceuticals, Inc. (2)
Adamas Pharmaceuticals Inc (9)
Adaptimmune Therapeutics PLC (5)
Adhera Therapeutics, Inc. (11)
ADiTx Therapeutics, Inc. (1)
ADMA BIOLOGICS, INC. (3)
ADURO BIOTECH, INC. (4)
Advaxis, Inc. (2)
Adverum Biotechnologies, Inc. (12)
Aeglea BioTherapeutics, Inc. (4)
Aerovate Therapeutics, Inc. (3)
AGENUS INC (23)
AgeX Therapeutics, Inc. (1)
AGIOS PHARMACEUTICALS INC (13)
AILERON THERAPEUTICS INC (4)
Aimmune Therapeutics, Inc. (7)
AKCEA THERAPEUTICS, INC. (6)
Akebia Therapeutics, Inc. (9)
Akero Therapeutics, Inc. (1)
Akouos, Inc. (2)
ALBIREO PHARMA, INC. (9)
Aldeyra Therapeutics, Inc. (7)
Alector, Inc. (2)
Alexion Pharmaceuticals (1)
Aligos Therapeutics, Inc. (2)
Alkermes plc. (6)
Allakos Inc. (3)
Allena Pharmaceuticals, Inc. (4)
Alliqua BioMedical, Inc. (2)
Allogene Therapeutics, Inc. (7)
Allovir, Inc. (4)
ALNYLAM PHARMACEUTICALS, INC. (14)
Alpha Healthcare Acquisition Corp. (5)
ALPINE IMMUNE SCIENCES, INC. (5)
AMARILLO BIOSCIENCES INC (1)
AMARIN CORP PLC (9)
AMICUS THERAPEUTICS, INC. (7)
AmpliPhi Biosciences Corp (11)
ANAPTYSBIO INC (6)
ANAVEX LIFE SCIENCES CORP. (2)
Anika Therapeutics (11)
Annexon, Inc. (2)
Apellis Pharmaceuticals, Inc. (9)
APPLIED GENETIC TECHNOLOGIES CORP (6)
Applied Molecular Transport Inc. (4)
Aptevo Therapeutics Inc. (3)
Aptinyx Inc. (1)
AQUINOX PHARMACEUTICALS, INC (10)
Aravive, Inc. (4)
Arbutus Biopharma Corp (3)
ARCA biopharma, Inc. (15)
Arcellx, Inc. (1)
Arcturus Therapeutics Holdings Inc. (4)
Arcus Biosciences, Inc. (3)
Arcutis Biotherapeutics, Inc. (2)
ARDELYX, INC. (6)
ARENA PHARMACEUTICALS INC (5)
Aridis Pharmaceuticals, Inc. (1)
ARROWHEAD PHARMACEUTICALS, INC. (9)
Arsanis, Inc. (7)
Artiva Biotherapeutics, Inc. (1)
ARYA Sciences Acquisition Corp II (2)
Atara Biotherapeutics, Inc. (7)
Athenex, Inc. (1)
ATOSSA GENETICS INC (8)
Atreca, Inc. (6)
aTYR PHARMA INC (5)
Aura Biosciences, Inc. (1)
Aurinia Pharmaceuticals Inc. (3)
AVEO PHARMACEUTICALS INC (11)
Avidity Biosciences, Inc. (4)
Avita Therapeutics, Inc. (4)
AVROBIO, Inc. (1)
Axcella Health Inc. (3)
Ayala Pharmaceuticals, Inc. (1)
BCTG Acquisition Corp. (1)
Beam Therapeutics Inc. (5)
BeiGene, Ltd. (1)
BELLICUM PHARMACEUTICALS, INC (11)
BICYCLE THERAPEUTICS Ltd (1)
Big Cypress Acquisition Corp. (2)
BIO-PATH HOLDINGS INC (2)
bioAffinity Technologies, Inc. (2)
BioAtla, Inc. (2)
BioCardia, Inc. (7)
BIOCEPT INC (8)
BIOCRYST PHARMACEUTICALS INC (2)
Biogen Inc. (11)
BIOMARIN PHARMACEUTICAL INC (3)
Biomea Fusion, Inc. (2)
BioRestorative Therapies, Inc. (3)
BIOSPECIFICS TECHNOLOGIES CORP (9)
Biostage, Inc. (1)
BIOTIME INC (7)
BioXcel Therapeutics, Inc. (2)
Black Diamond Therapeutics, Inc. (2)
Blue Water Vaccines Inc. (1)
bluebird bio, Inc. (11)
Blueprint Medicines Corp (6)
Bolt Biotherapeutics, Inc. (4)
BridgeBio Pharma, Inc. (1)
C4 Therapeutics, Inc. (2)
Cabaletta Bio, Inc. (2)
CALADRIUS BIOSCIENCES, INC. (5)
Calithera Biosciences, Inc. (4)
Calyxt, Inc. (1)
CANCER GENETICS, INC (5)
Candel Therapeutics, Inc. (2)
CAPRICOR THERAPEUTICS, INC. (12)
Capstone Therapeutics Corp. (1)
CareDx, Inc. (5)
Caribou Biosciences, Inc. (3)
CASI Pharmaceuticals, Inc. (3)
CASTLE BIOSCIENCES INC (17)
Castle Creek Biosciences, Inc. (3)
CATABASIS PHARMACEUTICALS INC (2)
CATALYST BIOSCIENCES, INC. (5)
CATALYST PHARMACEUTICALS, INC. (7)
Celcuity Inc. (6)
Celldex Therapeutics, Inc. (13)
Cellectar Biosciences, Inc. (3)
Cellular Biomedicine Group, Inc. (6)
Celsion CORP (3)
Centessa Pharmaceuticals Ltd (1)
Chanticleer Holdings, Inc. (1)
Chardan Healthcare Acquisition Corp. (9)
Chelsea Worldwide Inc. (2)
ChemoCentryx, Inc. (6)
CHIMERIX INC (11)
Cidara Therapeutics, Inc. (8)
CM Life Sciences III Inc. (2)
Codiak BioSciences, Inc. (3)
Coherus BioSciences, Inc. (2)
COMPASS Pathways plc (1)
Conatus Pharmaceuticals Inc. (7)
CONCERT PHARMACEUTICALS, INC. (2)
Consonance-HFW Acquisition Corp. (1)
Constellation Alpha Capital Corp. (8)
CONSTELLATION PHARMACEUTICALS INC (4)
CONTRAFECT Corp (2)
Corbus Pharmaceuticals Holdings, Inc. (7)
Cortexyme, Inc. (2)
Corvus Pharmaceuticals, Inc. (5)
Crinetics Pharmaceuticals, Inc. (2)
CRISPR Therapeutics AG (7)
CTI BIOPHARMA CORP (4)
Cullinan Oncology, LLC (1)
CURIS INC (4)
Cyclacel Pharmaceuticals, Inc. (6)
Cyclerion Therapeutics, Inc. (3)
Cytokinetics, Incorporated (9)
CytomX Therapeutics, Inc. (2)
CYTORI THERAPEUTICS, INC. (7)
CYTRX CORP (7)
Day One Biopharmaceuticals Holding Co LLC (2)
DBV Technologies S.A. (2)
Decibel Therapeutics, Inc. (2)
Deciphera Pharmaceuticals, Inc. (4)
Denali Therapeutics Inc. (2)
Dermavant Sciences Ltd (3)
Dermira, Inc. (4)
Design Therapeutics, Inc. (2)
DiaMedica Therapeutics Inc. (6)
Dicerna Pharmaceuticals Inc (5)
Diffusion Pharmaceuticals Inc. (2)
DYADIC INTERNATIONAL INC (5)
Dynamics Special Purpose Corp. (6)
DYNAVAX TECHNOLOGIES CORP (8)
Dyne Therapeutics, Inc. (5)
Eagle Pharmaceuticals, Inc. (2)
Edge Therapeutics, Inc. (2)
Editas Medicine, Inc. (1)
Eidos Therapeutics, Inc. (3)
Eiger BioPharmaceuticals, Inc. (5)
Emerald Bioscience, Inc. (4)
Emergent BioSolutions Inc. (7)
Enanta Pharmaceuticals, Inc. (6)
Enochian Biosciences Inc (4)
Entrada Therapeutics, Inc. (2)
Environmental Impact Acquisition Corp (4)
ENZON PHARMACEUTICALS, INC. (2)
Epizyme, Inc. (7)
Equillium, Inc. (1)
Erasca, Inc. (2)
Esperion Therapeutics, Inc. (7)
Evelo Biosciences, Inc. (3)
EXACT SCIENCES CORP (13)
Exelixis (35)
EXICURE, INC. (5)
FATE THERAPEUTICS INC (9)
FENNEC PHARMACEUTICALS INC. (2)
Fibrocell Science, Inc. (3)
FIBROGEN INC (1)
Finch Therapeutics Group, Inc. (4)
FIVE PRIME THERAPEUTICS INC (5)
Flex Pharma, Inc. (2)
Flexion Therapeutics Inc (10)
FLUOROPHARMA MEDICAL, INC. (2)
Foghorn Therapeutics Inc. (3)
Forma Therapeutics Holdings, Inc., (4)
Forty Seven, Inc. (3)
Frequency Therapeutics, Inc. (7)
FS Development Corp. (1)
Fusion Pharmaceuticals Inc. (4)
G1 Therapeutics, Inc. (2)
GALECTIN THERAPEUTICS INC (1)
Galecto Inc. (2)
Gemphire Therapeutics Inc. (6)
Gene Biotherapeutics, Inc. (3)
GENELUX CORP (4)
Generation Bio Co. (3)
GENOCEA BIOSCIENCES, INC. (5)
GeoVax Labs, Inc. (5)
GERON CORP (9)
Global Blood Therapeutics, Inc. (5)
GLYCOMIMETICS INC (5)
GOLDENWELL BIOTECH, INC. (1)
Gossamer Bio, Inc. (3)
Grail, Inc. (3)
Graphite Bio, Inc. (5)
Gritstone Oncology, Inc. (7)
GT Biopharma, Inc. (2)
GTX INC (8)
GX Acquisition Corp. (2)
HALOZYME THERAPEUTICS INC (8)
HARBOR DIVERSIFIED, INC. (1)
Harpoon Therapeutics, Inc. (3)
HEAT BIOLOGICS, INC. (8)
HedgePath Pharmaceuticals, Inc. (1)
HEMISPHERX BIOPHARMA INC (5)
HERON THERAPEUTICS, INC. (9)
HISTOGENICS CORP (8)
Homology Medicines, Inc. (4)
HOOKIPA Pharma Inc. (2)
HUMANIGEN, INC (2)
iBio, Inc. (2)
Icosavax, Inc. (1)
IDEAYA Biosciences, Inc. (5)
IDERA PHARMACEUTICALS, INC. (4)
IGM Biosciences, Inc. (2)
IMMUNE PHARMACEUTICALS INC (1)
Immuneering Corp (1)
ImmunoCellular Therapeutics, Ltd. (1)
IMMUNOGEN INC (13)
IMMUNOMEDICS INC (1)
IMPEL NEUROPHARMA INC (1)
Incyte (5)
INFINITY PHARMACEUTICALS, INC. (14)
Inhibikase Therapeutics, Inc. (1)
Inhibrx, Inc. (2)
InMed Pharmaceuticals Inc. (1)
Inmune Bio, Inc. (1)
INOVIO PHARMACEUTICALS, INC. (4)
Inozyme Pharma, Inc. (2)
INSMED Inc (12)
Intellia Therapeutics, Inc. (6)
INTERCEPT PHARMACEUTICALS, INC. (11)
International Stem Cell CORP (6)
Invitae Corp (4)
IONIS PHARMACEUTICALS INC (3)
IOVANCE BIOTHERAPEUTICS, INC. (11)
IRONWOOD PHARMACEUTICALS INC (16)
Isoray, Inc. (4)
iTeos Therapeutics, Inc. (1)
Janux Therapeutics, Inc. (1)
Jounce Therapeutics, Inc. (4)
Kadmon Holdings, Inc. (2)
KalVista Pharmaceuticals, Inc. (5)
Karuna Therapeutics, Inc. (2)
Karyopharm Therapeutics Inc. (6)
Keros Therapeutics, Inc. (3)
Kezar Life Sciences, Inc. (2)
Kindred Biosciences, Inc. (4)
Kiniksa Pharmaceuticals, Ltd. (5)
Kinnate Biopharma Inc. (2)
Kiromic Biopharma, Inc. (6)
KIWA BIO-TECH PRODUCTS GROUP CORP (1)
Kodiak Sciences Inc. (1)
Kronos Bio, Inc. (1)
Krystal Biotech, Inc. (17)
Kura Oncology, Inc. (15)
Kymera Therapeutics, Inc. (1)
LEAP THERAPEUTICS, INC. (8)
LEXICON PHARMACEUTICALS, INC. (1)
LianBio (5)
LifeSci Acquisition Corp. (1)
Ligand Pharmaceuticals Incorporated (7)
Locust Walk Acquisition Corp. (2)
LogicBio Therapeutics, Inc. (1)
LONGEVERON LLC (1)
Lyell Immunopharma, Inc. (5)
MACROGENICS INC (12)
MADRIGAL PHARMACEUTICALS, INC. (6)
Magenta Therapeutics, Inc. (4)
MANNKIND CORP (3)
MARIZYME INC (2)
MATEON THERAPEUTICS INC (8)
Matinas BioPharma Holdings, Inc. (2)
MAXCYTE, INC. (9)
MEDICINOVA INC (2)
MeiraGTx Holdings plc (9)
MERRIMACK PHARMACEUTICALS INC (12)
Mersana Therapeutics, Inc. (4)
Merus N.V. (3)
Metacrine, Inc. (2)
Millendo Therapeutics, Inc. (7)
MiMedx Group, Inc. (11)
Minerva Neurosciences, Inc. (1)
MIRAGEN THERAPEUTICS, INC. (12)
Mirati Therapeutics, Inc. (9)
Mirum Pharmaceuticals, Inc. (4)
Moderna, Inc. (2)
Molecular Templates, Inc. (12)
Moleculin Biotech, Inc. (2)
Momenta Pharmaceuticals, Inc. (16)
Monte Rosa Therapeutics, Inc. (3)
Morphic Holding, Inc. (2)
MUSTANG BIO, INC. (5)
Myriad Genetics, Inc. (13)
NantKwest, Inc. (22)
Natera, Inc. (5)
NAVIDEA BIOPHARMACEUTICALS, INC. (1)
NEUROBIOLOGICAL TECHNOLOGIES INC (4)
NEUROCRINE BIOSCIENCES INC (5)
Neurotrope, Inc. (1)
NexImmune, Inc. (2)
NextCure, Inc. (4)
Nkarta, Inc. (11)
NORTHWEST BIOTHERAPEUTICS INC (4)
NOVAVAX INC (27)
Novus Therapeutics, Inc. (6)
NTN BUZZTIME INC (14)
Nurix Therapeutics, Inc. (6)
Ohr Pharmaceutical Inc (10)
Olivia Ventures, Inc. (1)
Omega Therapeutics, Inc. (3)
OncoCyte Corp (6)
Oncorus, Inc. (6)
ONCOSEC MEDICAL Inc (8)
OPGEN INC (10)
Ophthotech Corp. (7)
Opko Health, Inc. (2)
ORAGENICS INC (3)
Orchard Therapeutics plc (1)
Organicell Regenerative Medicine, Inc. (1)
Organogenesis Holdings Inc. (10)
ORGANOVO HOLDINGS, INC. (7)
Oric Pharmaceuticals, Inc. (2)
Outlook Therapeutics, Inc. (8)
Passage BIO, Inc. (4)
PDL BIOPHARMA, INC. (10)
Pfenex Inc. (4)
PhaseBio Pharmaceuticals Inc (1)
Phio Pharmaceuticals Corp. (4)
PIERIS PHARMACEUTICALS, INC. (4)
PLURISTEM THERAPEUTICS INC (1)
PMV Pharmaceuticals, Inc. (2)
POLARITYTE, INC. (7)
PORTOLA PHARMACEUTICALS INC (3)
Poseida Therapeutics, Inc. (4)
Praxis Precision Medicines, Inc. (3)
PRECISION BIOSCIENCES INC (10)
Prelude Therapeutics Inc (3)
Prevail Therapeutics Inc. (1)
Principia Biopharma Inc. (3)
Progenics Pharmaceuticals, Inc. (3)
Prometheus Biosciences, Inc. (2)
Protagenic Therapeutics, Inc. (2)
Protagonist Therapeutics, Inc (8)
Protalix BioTherapeutics, Inc. (2)
PROTEON THERAPEUTICS INC (3)
PROTEOSTASIS THERAPEUTICS, INC. (10)
Prothena Corp plc (3)
PTC THERAPEUTICS, INC. (5)
PUMA BIOTECHNOLOGY, INC. (5)
Pyxis Oncology, Inc. (1)
Radius Health, Inc. (11)
RAPT Therapeutics, Inc. (4)
RECURSION PHARMACEUTICALS, INC. (10)
Regeneron Pharmaceuticals (18)
REGENXBIO Inc. (14)
Regulus Therapeutics Inc. (12)
Relay Therapeutics, Inc. (1)
Repare Therapeutics Inc. (11)
Replimune Group, Inc. (3)
Retrophin, Inc. (1)
Revolution Medicines, Inc. (10)
REXAHN PHARMACEUTICALS, INC. (13)
Rezolute, Inc. (2)
RHYTHM PHARMACEUTICALS, INC. (3)
RIGEL PHARMACEUTICALS INC (8)
RITTER PHARMACEUTICALS INC (2)
ROCKET PHARMACEUTICALS, INC. (9)
Rubius Therapeutics, Inc. (2)
Sage Therapeutics, Inc. (10)
Sana Biotechnology, Inc. (2)
SANGAMO THERAPEUTICS, INC (11)
Sarepta Therapeutics, Inc. (12)
Savara Inc (6)
Scholar Rock Holding Corp (1)
SEATTLE GENETICS INC (8)
SELECTA BIOSCIENCES INC (7)
SELLAS Life Sciences Group, Inc. (8)
Sensei Biotherapeutics, Inc. (1)
SERA PROGNOSTICS, INC. (4)
Seres Therapeutics, Inc. (5)
Sesen Bio, Inc. (3)
Shattuck Labs, Inc. (2)
Sierra Oncology, Inc. (6)
Sigilon Therapeutics, Inc. (5)
Silverback Therapeutics, Inc. (4)
SOLENO THERAPEUTICS INC (3)
Solid Biosciences Inc. (4)
SOLIGENIX, INC. (2)
SOPHIRIS BIO INC. (1)
Sorrento Therapeutics, Inc. (6)
Spectrum Pharmaceuticals, Inc. (8)
Spero Therapeutics, Inc. (3)
SPHERIX INC (1)
Spinning Eagle Acquisition Corp. (4)
Spring Bank Pharmaceuticals, Inc. (5)
SpringWorks Therapeutics, Inc. (1)
SPRUCE BIOSCIENCES, INC. (2)
SQZ Biotechnologies Co (1)
Stellar Biotechnologies, Inc. (7)
Stoke Therapeutics, Inc. (5)
Summit Therapeutics Inc. (1)
SUNESIS PHARMACEUTICALS INC (10)
Surface Oncology, Inc. (3)
SUTRO BIOPHARMA, INC. (2)
SYNLOGIC, INC. (4)
Synthetic Biologics, Inc. (2)
Syros Pharmaceuticals, Inc. (2)
T2 Biosystems, Inc. (10)
Talaris Therapeutics, Inc. (2)
Taysha Gene Therapies, Inc. (2)
TCR2 THERAPEUTICS INC. (3)
TENAX THERAPEUTICS, INC. (2)
Tenaya Therapeutics, Inc. (2)
Tocagen Inc (6)
Tonix Pharmaceuticals Holding Corp. (3)
Tracon Pharmaceuticals, Inc. (2)
Translate Bio, Inc. (1)
TREVENA INC (8)
Trovagene, Inc. (5)
TScan Therapeutics, Inc. (3)
Turning Point Therapeutics, Inc. (7)
Twist Bioscience Corp (12)
Tyra Biosciences, Inc. (4)
U.S. Stem Cell, Inc. (5)
Ultragenyx Pharmaceutical Inc. (18)
uniQure N.V. (3)
Unity Biotechnology, Inc. (2)
Unum Therapeutics Inc. (4)
UroGen Pharma Ltd. (2)
Vanda Pharmaceuticals Inc. (11)
Vaxart, Inc. (5)
Vaxcyte, Inc. (6)
VBI Vaccines Inc (16)
VERACYTE, INC. (5)
Verastem, Inc. (3)
Vericel Corp (4)
Vertex Pharmaceuticals Inc (7)
Verve Therapeutics, Inc. (4)
VICAL INC (4)
Viela Bio, Inc. (1)
Vigil Neuroscience, Inc. (1)
Viking Therapeutics, Inc. (4)
Vir Biotechnology, Inc. (2)
VistaGen Therapeutics, Inc. (3)
VITAL THERAPIES INC (4)
VITRO DIAGNOSTICS INC (1)
Vor Biopharma Inc. (3)
Voyager Therapeutics, Inc. (10)
Werewolf Therapeutics, Inc. (3)
WINDTREE THERAPEUTICS INC (8)
XBiotech Inc. (4)
Xencor Inc (9)
Xenetic Biosciences, Inc. (2)
Xenon Pharmaceuticals Inc. (5)
Xilio Therapeutics, Inc. (1)
XOMA Corp (8)
Y-mAbs Therapeutics, Inc. (1)
YIELD10 BIOSCIENCE, INC. (7)
ZAFGEN, INC. (8)
Zai Lab Ltd (1)
Zentalis Pharmaceuticals, LLC (10)
ZIOPHARM ONCOLOGY INC (5)
Zymeworks Inc. (2)

Recent Contracts

March 15, 2024 Addendum 1 to Lease for Ocala office (HEMISPHERX BIOPHARMA INC, Filed With SEC on April 19, 2024)
October 4, 2023 Lease extension for Riverton office (HEMISPHERX BIOPHARMA INC, Filed With SEC on April 19, 2024)
Lease Agreement for Suite 510, dated January 1, 2024, between Insight Genetics, Inc. and MPC Holdings, LLC (OncoCyte Corp, Filed With SEC on April 16, 2024)
Lease Agreement for Suite 410, dated January 1, 2024, between Insight Genetics, Inc. and MPC Holdings, LLC (OncoCyte Corp, Filed With SEC on April 16, 2024)
Lease Agreement for Suite 103, dated January 1, 2024, between Insight Genetics, Inc. and MPC Holdings, LLC (OncoCyte Corp, Filed With SEC on April 16, 2024)
Second Amendment to Lease Agreement, dated March 25, 2024, by and between ARE-San Francisco No. 19 Owner, LLC and the Registrant (Nurix Therapeutics, Inc., Filed With SEC on April 10, 2024)
Amendment No. 6, dated as of March 5, 2024, to Lease Agreement by and between ARE-708 Quince Orchard, LLC and Adaptive Phage Therapeutics, Inc (Chardan Healthcare Acquisition Corp., Filed With SEC on April 4, 2024)
Amendment No. 5, dated as of February 2, 2023, to Lease Agreement by and between ARE-708 Quince Orchard, LLC and Adaptive Phage Therapeutics, Inc (Chardan Healthcare Acquisition Corp., Filed With SEC on April 4, 2024)
Amendment No. 4, dated as of September 27, 2022, to Lease Agreement by and between ARE-708 Quince Orchard, LLC and Adaptive Phage Therapeutics, Inc (Chardan Healthcare Acquisition Corp., Filed With SEC on April 4, 2024)
Amendment No. 3, dated as of July 15, 2021, to Lease Agreement by and between ARE-708 Quince Orchard, LLC and Adaptive Phage Therapeutics, Inc (Chardan Healthcare Acquisition Corp., Filed With SEC on April 4, 2024)
Amendment No. 2, dated as of July 8, 2021, to Lease Agreement by and between ARE-708 Quince Orchard, LLC and Adaptive Phage Therapeutics, Inc (Chardan Healthcare Acquisition Corp., Filed With SEC on April 4, 2024)
Amendment No. 1, dated as of October 28, 2020, to Lease Agreement by and between ARE-708 Quince Orchard, LLC and Adaptive Phage Therapeutics, Inc (Chardan Healthcare Acquisition Corp., Filed With SEC on April 4, 2024)
Lease Agreement, dated as of August 9, 2019, by and between ARE-708 Quince Orchard, LLC and Adaptive Phage Therapeutics, Inc (Chardan Healthcare Acquisition Corp., Filed With SEC on April 4, 2024)
Office Lease by and between Regus Management Group, LLC and Achieve Life Sciences, Inc., commencing March 1, 2024 (ACHIEVE LIFE SCIENCES, INC., Filed With SEC on March 28, 2024)
Second Amendment to Lease, dated April 20, 2018, by and between the Registrant and BMR-Medical Center Drive LLC (GLYCOMIMETICS INC, Filed With SEC on March 27, 2024)
First Amendment to Lease with HCP Torreyana, dated January 16, 2019 (BioAtla, Inc., Filed With SEC on March 26, 2024)
Third Amendment to Lease Agreement, by and between Korro Bio, Inc. and ARE-MA Region No. 59, LLC, dated October 20, 2023 (Frequency Therapeutics, Inc., Filed With SEC on March 26, 2024)
Second Amendment to Lease Agreement, by and between Korro Bio, Inc. and ARE-MA Region No. 59, LLC, dated August 31, 2022 (Frequency Therapeutics, Inc., Filed With SEC on March 26, 2024)
Second Amendment to Lease dated May 6, 2021 by and between Registrant and ARE-Maryland No. 50, LLC (Synthetic Biologics, Inc., Filed With SEC on March 25, 2024)
Lease dated April 14, 2015 between Registrant. and MCC3, LLC (Synthetic Biologics, Inc., Filed With SEC on March 25, 2024)
Lease, Amendment, dated January 2, 2024, by and between the Registrant and PDM 930 Unit, LLC (Aerovate Therapeutics, Inc., Filed With SEC on March 25, 2024)
Lease Agreement, dated as of September 8, 2021, by and between ARE-MA Region No. 24, LLC and the Registrant, as amended to date (Stoke Therapeutics, Inc., Filed With SEC on March 25, 2024)
First Amendment to Office Lease Agreement, dated March 19, 2024, by and between ARCA biopharma, Inc. and Lotus Church Ranch, LLC (ARCA biopharma, Inc., Filed With SEC on March 22, 2024)
Third Amendment to Lease, between the Registrant and Fabric 2676 State, LLC, a California limited liability company, dated March 18, 2024 (Tyra Biosciences, Inc., Filed With SEC on March 19, 2024)
Extension of Commercial Lease by and between Duley Road, LLC and Altor BioScience Manufacturing Company, LLC, dated October 3, 2023 (NantKwest, Inc., Filed With SEC on March 19, 2024)
Third Amendment to Office Lease, dated January 17, 2024, by and between the Registrant and Hudson Metro Center, LLC (Mirum Pharmaceuticals, Inc., Filed With SEC on March 15, 2024)
Office Lease, dated January 17, 2024, by and between the Registrant and Hudson Metro Center, LLC (Mirum Pharmaceuticals, Inc., Filed With SEC on March 15, 2024)
First Amendment to Lease, dated as of March 9, 2023, by and between the Company and Bala Plaza Property, Inc (ZAFGEN, INC., Filed With SEC on March 14, 2024)
Lease, dated as of August 8, 2019, by and between Larimar Therapeutics, Inc. and Bala Plaza Property, Inc (ZAFGEN, INC., Filed With SEC on March 14, 2024)
Lease Agreement, date (Entrada Therapeutics, Inc., Filed With SEC on March 13, 2024)
Office Lease dated June 27, 2023 between KBSIII Towers at Emeryville, LLC and XOMA (US) LLC (XOMA Corp, Filed With SEC on March 8, 2024)
Fifth Lease Amendment, dated as of November 29, 2023, by and between the Company and Duke & Duke (REXAHN PHARMACEUTICALS, INC., Filed With SEC on March 8, 2024)
Lease Agreement between DBV Technologies Inc. and SIG 106 LLC, dated March 28, 2022 (DBV Technologies S.A., Filed With SEC on March 7, 2024)
Office Lease between the registrant and SCI DANTON MALAKOFF, dated October 2, 2023 (English translation) (DBV Technologies S.A., Filed With SEC on March 7, 2024)
Lease Agreement by and between 7495 RP, LLC and Cartesian Therapeutics, Inc. dated February 28, 2024 (SELECTA BIOSCIENCES INC, Filed With SEC on March 7, 2024)
Second Amendment to Lease Agreement by and between 704 Quince Orchard Owner, LLC and Cartesian Therapeutics, Inc. dated May 3, 2021 (SELECTA BIOSCIENCES INC, Filed With SEC on March 7, 2024)
First Amendment to Lease Agreement by and between 704 Quince Orchard Owner, LLC and Cartesian Therapeutics, Inc. dated March 22, 2021 (SELECTA BIOSCIENCES INC, Filed With SEC on March 7, 2024)
Lease Agreement by and between 704 Quince Orchard Owner, LLC and Cartesian Therapeutics, Inc. dated May 11, 2018 (SELECTA BIOSCIENCES INC, Filed With SEC on March 7, 2024)
Fourth Amendment to Lease between WLC Three VI, L.L.C. and the Registrant, dated as of November 22, 2023 (Aldeyra Therapeutics, Inc., Filed With SEC on March 7, 2024)
First Amendment to Office/Laboratory Lease, by and between Gritstone bio, Inc. and RREF II Kenmore Lessor III LLC and RREF II Kenmore Lessor IV LLC, effective as of September 20,... (Gritstone Oncology, Inc., Filed With SEC on March 5, 2024)